To monitor the quality of life and degree of improvement in the stages of chronic kidney disease patients

Sonali Singh 1, *, Kanchan Sharma 1, Joginder Rakesh Kumari 1, Ekta Dhull 1 and Anshu Jain 2

1 Department of Pharmacy Practice, Chandigarh College of Pharmacy, Punjab, Mohali, India 140307
2 Department of Quality, Operations & Quality manager, Grecian super-speciality hospital, Punjab, Mohali, India 16006
 
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2023, 13(02), 291–301.
Article DOI: 10.30574/wjbphs.2023.13.2.0096
Publication history: 
Received on 12 January 2023; revised on 13 February 2023; accepted on 16 February 2023
 
Abstract: 
Chronic kidney disease (CKD) is a global burden on healthcare systems and is recognized as a major threat to population which resulted in reduced quality of life. The key objectives of the research were to evaluate the compliance of prescribing medication patterns with standard treatment guidelines and to utilize standard questionnaires for the assessment of the quality of life. This study demonstrates that with disease progression, quality of life gets deteriorated in advanced stages. The questionnaire used in this study results that the majority of the patients were from stable economic backgrounds following renal diet plans and taking medications on time. Since the treatment course was as per the standard treatment guidelines, which showed a significant impact on the quality of life of patients with chronic renal disease.
 
Keywords: 
CKD; Quality of life; Prescribing patterns; Grades of CKD
 
Full text article in PDF: